JP2020508993A - ざ瘡を処置するための組成物 - Google Patents

ざ瘡を処置するための組成物 Download PDF

Info

Publication number
JP2020508993A
JP2020508993A JP2019544856A JP2019544856A JP2020508993A JP 2020508993 A JP2020508993 A JP 2020508993A JP 2019544856 A JP2019544856 A JP 2019544856A JP 2019544856 A JP2019544856 A JP 2019544856A JP 2020508993 A JP2020508993 A JP 2020508993A
Authority
JP
Japan
Prior art keywords
solvent
ethoxyethoxy
ethanol
pharmaceutical composition
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2019544856A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020508993A5 (enExample
Inventor
ユージーン クーパー，
ユージーン クーパー，
マシュー カラハン，
マシュー カラハン，
マイケル トゥルン，
マイケル トゥルン，
デイビッド ディカソン，
デイビッド ディカソン，
Original Assignee
ボタニクス ファーマシューティカルズ リミテッド
ボタニクス ファーマシューティカルズ リミテッド
ボタニクス ファーマシューティカルズ， インコーポレイテッド
ボタニクス ファーマシューティカルズ， インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2017900498A external-priority patent/AU2017900498A0/en
Application filed by ボタニクス ファーマシューティカルズ リミテッド, ボタニクス ファーマシューティカルズ リミテッド, ボタニクス ファーマシューティカルズ， インコーポレイテッド, ボタニクス ファーマシューティカルズ， インコーポレイテッド filed Critical ボタニクス ファーマシューティカルズ リミテッド
Priority claimed from PCT/AU2018/050117 external-priority patent/WO2018148795A1/en
Publication of JP2020508993A publication Critical patent/JP2020508993A/ja
Publication of JP2020508993A5 publication Critical patent/JP2020508993A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/08—Ethers or acetals acyclic, e.g. paraformaldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2019544856A 2017-02-15 2018-02-14 ざ瘡を処置するための組成物 Pending JP2020508993A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201762459312P 2017-02-15 2017-02-15
AU2017900498A AU2017900498A0 (en) 2017-02-15 Compositions for Treating Acne
US62/459,312 2017-02-15
AU2017900498 2017-02-15
PCT/AU2018/050117 WO2018148795A1 (en) 2017-02-15 2018-02-14 Compositions for treating acne

Publications (2)

Publication Number Publication Date
JP2020508993A true JP2020508993A (ja) 2020-03-26
JP2020508993A5 JP2020508993A5 (enExample) 2021-01-14

Family

ID=67766788

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019544856A Pending JP2020508993A (ja) 2017-02-15 2018-02-14 ざ瘡を処置するための組成物

Country Status (8)

Country Link
US (2) US20200022927A1 (enExample)
EP (1) EP3582763A4 (enExample)
JP (1) JP2020508993A (enExample)
CN (1) CN110430872A (enExample)
AU (1) AU2018221889A1 (enExample)
BR (1) BR112019017045A2 (enExample)
CA (1) CA3053507A1 (enExample)
IL (1) IL268715A (enExample)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007530515A (ja) * 2004-03-22 2007-11-01 ガルデルマ リサーチ アンド デベロップメント シリコネート化された剤及び溶解された活性成分を組み合わせた無水の薬剤組成物
US20100261795A1 (en) * 2009-04-08 2010-10-14 Pierre Fabre Dermocosmetique Usa Antiacneic compositions
WO2014066225A1 (en) * 2012-10-24 2014-05-01 Kulesza John E Low toxicity topical active agent delivery system
WO2014116653A1 (en) * 2013-01-22 2014-07-31 Coty Inc. Topical formulations and methods for the use thereof
JP2015514801A (ja) * 2012-04-27 2015-05-21 ダウ コーニング コーポレーションＤｏｗ Ｃｏｒｎｉｎｇ Ｃｏｒｐｏｒａｔｉｏｎ 基質に有効成分を送達するためのシリコーン系賦形剤を含有する局所用製剤組成物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2338124C (en) * 2001-02-26 2010-08-03 Valerie Dumont Dicianna Self-tanning composition in sheeted substrate
WO2009090495A2 (en) * 2007-12-07 2009-07-23 Foamix Ltd. Oil and liquid silicone foamable carriers and formulations
JP5964322B2 (ja) * 2011-01-13 2016-08-03 キュー エル ティー インク．ＱＬＴ Ｉｎｃ． 光増感剤の局所送達用医薬組成物及びその使用
WO2014081674A1 (en) * 2012-11-20 2014-05-30 Allergan, Inc. Topical dapsone and dapsone/adapalene compositions and methods for use thereof
EP3065702B1 (en) * 2013-10-31 2023-06-07 Sun Pharmaceutical Industries Ltd Topical pharmaceutical composition of acitretin

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007530515A (ja) * 2004-03-22 2007-11-01 ガルデルマ リサーチ アンド デベロップメント シリコネート化された剤及び溶解された活性成分を組み合わせた無水の薬剤組成物
US20100261795A1 (en) * 2009-04-08 2010-10-14 Pierre Fabre Dermocosmetique Usa Antiacneic compositions
JP2015514801A (ja) * 2012-04-27 2015-05-21 ダウ コーニング コーポレーションＤｏｗ Ｃｏｒｎｉｎｇ Ｃｏｒｐｏｒａｔｉｏｎ 基質に有効成分を送達するためのシリコーン系賦形剤を含有する局所用製剤組成物
WO2014066225A1 (en) * 2012-10-24 2014-05-01 Kulesza John E Low toxicity topical active agent delivery system
WO2014116653A1 (en) * 2013-01-22 2014-07-31 Coty Inc. Topical formulations and methods for the use thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JOURNAL OF COSMETIC DERMATOLOGY, vol. 10, JPN6021042423, 2011, pages 324 - 329, ISSN: 0004788910 *

Also Published As

Publication number Publication date
US20220331269A1 (en) 2022-10-20
EP3582763A1 (en) 2019-12-25
CA3053507A1 (en) 2018-08-23
BR112019017045A2 (pt) 2020-04-14
AU2018221889A1 (en) 2019-09-05
CN110430872A (zh) 2019-11-08
IL268715A (en) 2019-10-31
EP3582763A4 (en) 2020-11-25
US20200022927A1 (en) 2020-01-23

Similar Documents

Publication Publication Date Title
US11890294B2 (en) Skin barrier composition
EP2691077B1 (en) Salicylic acid topical formulation
JP7012089B2 (ja) 皮膚炎および炎症性皮膚疾患の処置のためのカンナビノイドの製剤
US20220323401A1 (en) Formulations of cannabinoids for the treatment of acne
WO2018148786A1 (en) Formulations of cannabinoids for the treatment of acne
JP5667052B2 (ja) ダナゾールを含む経真皮医薬組成物
JP2020508993A (ja) ざ瘡を処置するための組成物
WO2018148795A1 (en) Compositions for treating acne
AU2016427261A1 (en) Pharmaceutical compositions
US20230320984A1 (en) Tofacitinib-containing anhydrous elastomer-based gel formulations
US20250170085A1 (en) Topical formulation to decrease skin inflammation or redness
JPS6028927A (ja) 皮膚外用剤
US20220313621A1 (en) Formulations of cannabinoids for the treatment of psoriasis
Sitaram Design of cream based formulation for skin psoriasis
JPH111442A (ja) 皮膚外用組成物

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20201126

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20201126

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20211027

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220127

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220601

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20221223